Newsletter registration

Austria.
Bridge to New Markets.

The Upper Austrian startup GENSPEED® Biotech develops a rapid test system for hospital bacteria and periodontal pathogens

GENSPEED®-Technology © GENSPEED® Biotech GmbH

Infections caused by antibiotic-resistant hospital bacteria that occur during hospital stays or infections with periodontal pathogens can result in serious consequences for affected patients. Both the detection of hospital bacteria in hospitals and the detection of periodontal pathogens in the dental field can take several days. The patient samples must either be examined through the use of lengthy in-house analyses or sent to external laboratories. With the rapid tests from GENSPEED® Biotech, hospital bacteria can be detected in the hospital laboratory in just 100 minutes, and periodontal pathogens can be detected in just 20 minutes directly at the dentist's practice. In both cases, rapid diagnosis allows for an immediate, targeted start of treatment. The GENSPEED immediate diagnosis system is a patented technology based on microfluid biochips, miniaturized optical detection and automation. In other words, the sample (e.g. from a nasal smear) is processed using standard methods and dripped into a so-called microfluid chip. No further intervention is required by the user, who can read the test result on the computer after a short time.

More information is available here.

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 16. Mittelstandstag

    07.11.2017, Frankfurt am Main, Germany

  • MEDICA 2017

    13.11. - 15.11.2017, Düsseldorf, Germany

Austria Map

Find the perfect location for your company

Austria offers the comfort and infrastracture of a western industrial nation. The high quality of life is an advantage when it comes to attracting top executives from around the world to our headquarters here.

Coca-Cola Austria

Logo
More testimonials

news from the business location Austria

The freedom to conduct research

The German-born quantum physicist Hanns-Christoph Nägerl of the University of Innsbruck received the Wittgenstein Award 2017 for ultracold many-body quantum systems. Hanns-Christoph Nägerl is one of the world’s leading quantum physicists in the field of ultracold many-body quantum systems.

The “privilege for industry” in the Austrian Trade Regulation Act

If a foreign company wants to be economically active in Austria, whether on a cross-border basis or by setting up a subsidiary or branch office, it will inevitably be confronted with the Austrian Trade Regulation Act.

More news All blog posts